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Abstract
Astroviruses are a leading cause of gastroenteritis in mammals and birds worldwide. Although historically thought to be
species-specific, increasing evidence suggests that astroviruses may cross species barriers. In this report, we used enzyme-
linked immunosorbent assays to screen sera from three distinct human cohorts involved in influenza studies in Memphis, TN
or Chapel Hill, NC, and Midwestern poultry abattoir workers for antibodies to turkey astrovirus type 2 (TAstV-2). Surprisingly,
26% of one cohort’s population was TAstV-2 positive as compared to 0 and 8.9% in the other cohorts. This cohort was
composed of people with exposure to turkeys in the Midwestern United States including abattoir workers, turkey growers,
and non-occupationally exposed participants. The odds of testing positive for antibodies against turkey astrovirus among
abattoir workers were approximately 3 times higher than the other groups. These studies suggest that people with contact
to turkeys can develop serological responses to turkey astrovirus. Further work is needed to determine if these exposures
result in virus replication and/or clinical disease.
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Introduction
Astroviruses are a diverse family of small, non-enveloped RNA
viruses that have been identified in a broad range of species,
including humans, wild birds, poultry, bats, dogs, and marine
mammals [1,2,3,4,5]. Surveillance using molecular diagnostic
methods demonstrates that human astroviruses (HAstV) are one of
the most important causes of pediatric acute gastroenteritis,
although outbreaks affecting adults and the elderly are also
frequently described [6]. Astroviruses can also be associated with
asymptomatic infections and in the case of animal astroviruses,
with non-enteric clinical diseases including hepatitis, nephritis, and
neurologic complications [7].
The Astroviridae family is divided into distinct Mamastrovirus and
Avastrovirus genera that share limited sequence identity. For
example, the capsid proteins of turkey astrovirus-2 (TAstV-2)
and human astrovirus type 1 (HAstV-1) share only 25% amino
acid similarity and are structurally distinct [8]. Although astrovirus
infections are thought to be species specific [7], the wide variety of
species infected, the genetic diversity of the family, and the
occurrence of recombination suggests that cross-species transmis-
sion of astroviruses could occur. In fact, distinct avian strains have
been transmitted across bird species [9,10,11]. More recently,
novel astrovirus strains have been discovered in humans that are
genetically similar to animal viruses including rat and swine [12].
To date, there have been no known infections of mammals with
avian astroviruses.
The objective of these studies was to screen human sera for
antibodies against TAstV-2. Included in our cohorts were adults
occupationally exposed to turkeys in the Midwestern US where
TAstV-2 has been identified [11,13]. Previous work has demon-
strated that poultry meat packers and slaughterhouse workers have
elevated antibody titers against a variety of avian viruses including
avian metapneumoviruses [14], avian leukosis/sarcoma virus [15],
reticuloendotheliosis virus [15,16], and Marek’s disease virus [17].
Similarly we now report that this population also has TAstV-2
antibodies. Compared to other population samplings, we found a
more robust and higher incidence of seroreactivity to TAstV-2.
These studies provide evidence that avian astroviruses can induce
serological responses in exposed humans but further studies are
needed to determine if they are associated with virus replication
and/or clinical disease.
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Materials and Methods
Study Samples
Samples were collected in compliance with 45 CFR 46 and the
Declaration of Helsinki. Institutional Review Boards of the
University of Iowa, St Jude Children’s Research Hospital and
the University of Tennessee Health Science Center/Le Bonheur
Children’s Hospital approved the study. At the time of enrolment,
written, informed consent was obtained from participants or their
parents/guardians, and assent was obtained from age-appropriate
participants. Limited quantities of archived human sera from
cohorts involved in institutional review board (IRB) approved
studies as described below were available for these studies. All
samples were coded by the originating laboratories prior to
providing them for astrovirus analysis.
Cohort A is an ongoing prospective study carried out at
LeBonheur Children’s Hospital in Memphis, TN. Eligible
participants included children and adults exhibiting influenza-like
illness as described in [18,19,20]. Samples were collected from
February to April 2012 in compliance with 45 CFR 46 and the
Declaration of Helsinki. Institutional Review Boards of St Jude
Children’s Research Hospital and the University of Tennessee
Health Science Center/Le Bonheur Children’s Hospital approved
the study.
Cohort B is an ongoing, prospective study carried out at the
University of North Carolina Family Medicine Center, an
academic outpatient primary care facility in Chapel Hill, NC as
described in [21,22]. Eligible participants were adults (greater than
or equal to18 years) receiving the influenza vaccine and samples
were collected between 2009 and 2011. All procedures were
approved by the Biomedical Institutional Review Board at the
University of North Carolina and St Jude Children’s Research
Hospital.
Cohort C was an IRB-approved study at the University of Iowa.
In the original cross-sectional study, from March 2007 to April
2008, a total of 57 turkey growers, 38 turkey meat processing plant
workers, and 82 occupationally unexposed workers that did not
interact with turkeys at the workplace on a daily basis from Iowa
and Illinois were enrolled after written informed consent was
obtained. Participants completed a questionnaire about their
demographic, occupational, and general health status. A blood
specimen for laboratory analysis was successfully obtained from
170 of 177 participants and serum was collected. The demo-
graphic characteristics of the study participants have been
published [14]. 160 serum samples were available for this study.
Capsid Protein Purification and Antibody Production
Recombinant HAstV-1 Oxford (GenBank L23513) and TAstV-
2 (NC005790.1) astrovirus capsid proteins were expressed in
baculovirus and purified as described [8,23]. Protein concentra-
tion was measured by BCA assay (Pierce, Rockford, IL). HAstV-1
polyclonal antiserum was generated from rabbits immunized with
HAstV-1 peptide (IPRSRASGHGYESD) and rabbit anti–TAstV-
2 was generated from TAstV-2 peptide (KHLEEEKNYWKNQ)
(ProSci, Poway, CA), epitopes within the acidic domain of the
astrovirus capsid protein.
Astrovirus Capsid ELISA
High binding–affinity polystyrene plates (Corning Incorporated,
Corning, NY) were coated with 0.05 mg/well of the astrovirus
capsid protein of interest or BSA (negative control) and incubated
overnight at 4uC. Plates were washed thrice with PBS in 0.05%
Tween-20 (PBST) and then blocked with 4% BSA in PBST for 2
hours at room temperature. Following extensive washing, diluted
human sera samples (1:100 unless otherwise noted) were added to
the plates and incubated for 1 hour at room temperature. After
another wash step, plates were incubated with 0.05 mg/mL of
anti-human, HRP-conjugated secondary antibody (Jackson Im-
munoResearch, West Grove, PA). Reactivity was assessed by using
a substrate reagent kit to detect HRP (R&D Systems, Minneapolis,
MN). To stop the reaction, 2N of H2SO4 was added to the plate.
Absorbance was read on a Multiskan Ascent microplate spectro-
photometer (ThermoFisher, Waltham, MA) at 450 nm. Samples
with capsid-specific absorbance greater than three times the
absorbance of the sample binding to BSA were considered
positive. All samples were tested in at least triplicate and
experiments repeated at least twice. End point titration was
performed on a subset of TAstV-2 positive samples (n = 12).
Competition ELISA
To monitor the specificity of the assay, a subset of the sera were
pre-incubated with 150 mg/mL of recombinant HAstV-1 or
TAstV-2 capsid protein or a 1:4 dilution of chicken astrovirus
viral stock (a generous gift of Dr. Holly Sellers, University of
Georgia, referenced in [24]) overnight at 4uC prior to use in the
ELISA as described above.
Statistical Analyses
Statistical analyses included Pearson’s Chi square and Fisher’s
exact tests to compare categorical variables and unpaired Student t
tests to compare continuous variables. Odds ratios and associated
confidence intervals (CIs) were calculated by using the traditional
method. Fisher’s exact method was used if data were sparse.
Analyses were performed using SPSS 18.0 software (IBM,
Armonk, NY).
Results
Although there is increasing evidence that astroviruses cross
species barriers, no studies to date have examined the seroprev-
alence of animal or avian astroviruses in humans. Thus, we
analysed archived human sera from three cohorts for the presence
of turkey astrovirus-2 (TAstV-2) and human astrovirus type 1
(HAstV-1) antibodies by antibody capture ELISA using purified
recombinant capsid proteins. Samples with absorbance greater
than 3-fold above background (binding to BSA) were considered
positive. As expected ,75% of the people had antibodies against
HAstV-1 ranging from 20% in Cohort A to 80–84% in Cohorts B
and C (Table 1). It is unclear if the low HAstV-1 positivity seen in
Cohort A was due to the young age of some of the participants.
Surprisingly 20% of the samples were TAstV-2 positive with the
highest number found in Cohort C (26.3%). End-point titration
was performed on twelve of the TAstV-2 positive samples and
demonstrated that 8% were positive at 1:1000, 75% were positive
to 1:10,000, and ,17% were positive to 1:100,000 dilutions
(Table 1). Unfortunately attempts to complement these findings
with western blot analysis were unsuccessful and there is not an
in vitro culture system for TAstV-2 to perform neutralization
studies. However, these studies suggest that antibodies against
TAstV-2 can be detected in humans.
To ensure that the responses were specific, competition ELISAs
were performed. Briefly, random sera samples from all cohorts
were pre-incubated with purified recombinant HAstV-1 or
TAstV-2 capsid prior to using in the ELISA. If the serum
antibodies are specific, pre-incubation with that capsid should
competitively inhibit binding to capsid coated on the plate
resulting in decreased absorbance. To determine the level of
inhibition achievable, polyclonal antibodies produced to specific
Avian Astrovirus Antibodies in Humans
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peptides within the HAstV-1 and TAstV-2 capsids were initially
tested (Figure 1A). Pre-incubation of sera with capsid proteins
resulted in significant decreases in absorbance. Incubating HAstV-
1 capsid with anti-HAstV-1 antibody decreased absorbance by
70.1% (p= 0.0137). In contrast, pre-incubation with TAstV-2
capsid had no significant inhibition. A similar trend was observed
with the TAstV-2 antibody where pre-incubation with the TAstV-
2 capsid decreased absorbance by 29.7% (p= 0.0018) while the
HAstV-1 capsid had no significant effect. Figure 1B demonstrates
that the polyclonal antisera are specific to their respective capsid
proteins with no cross-reactivity.
Due to limited quantities, only a small number of human sera
could be tested in the competition ELISAs. Of the HAstV-1
positive samples tested, pre-incubating the sera with HAstV-1
capsid led to a significant decrease in absorbance versus human
capsid protein (p = 0.0495, 0.0001, 0.0025, 0.0050, respectively).
In contrast, pre-incubation with TAstV-2 capsid protein had no
effect suggesting that the antibodies we are detecting are specific
for HAstV-1 (Figure 2A).
When the converse experiments were performed on TAstV-2
coated plates, pre-incubation of TAstV-2 capsid with the TAstV-2
positive sera led to significant decreases in absorbance (p = 0.0134,
0.0015, 0.0024, respectively) (Figure 2B). Pre-incubation with
HAstV-1 capsid did decrease the absorbance of one of the TAstV-
2 positive samples (Figure 2B). Finally, to determine if the TAstV-2
positive sera could be inhibited with other avian astroviruses, we
obtained a chicken astrovirus (CAstV, [23]) and pre-incubated it
with TAstV-2 positive and negative sera and measured binding to
TAstV-2 capsid. Incubation with CAstV had no impact on
absorbance (Figure 2C). In summation, these studies suggest that
the ELISA is measuring HAstV-1- and TAstV-2-specific antibod-
ies.
Twenty six percent of Cohort C participants were TAstV-2
positive. This cohort is composed of a population sampling of
adults occupationally exposed to turkeys in the Midwestern US
(Iowa and Illinois). In the original cross-sectional study conducted
from March 2007 to April 2008, a total of 57 turkey growers, 38
turkey meat processing plant workers, and 82 occupationally
unexposed controls from Iowa and Illinois were enrolled after
written informed consent was obtained. The demographic
characteristics of the study participants have been published
[14]. Briefly, most turkey growers used tobacco, were men, and
were significantly older than those of other groups. Most growers
were white, and most processing plant workers were Hispanic.
There were no significant differences in the chronic conditions
reported among the groups [14]. ‘‘Controls’’ were study partic-
ipants who did not interact with turkeys on a daily basis at the
workplace (i.e., those who were not turkey growers or meat-
processing plant workers) [14].
The majority of the study subjects (80.6%) were HAstV-1
positive and there was no difference in positivity between the study
Table 1. Serologic results of TAstV-2 and HAstV-1 antibody testing.
TAstV-2 positive HAstV-1 positive
Cohort A (n = 25) 0 (0.0%) 5 (20.0%)
Cohort B (n = 45) 4 (8.9%)1 38 (84.4%)
Cohort C (n = 160) 42 (26.3%)2 129 (80.6%)
14/4 samples positive to 1:100 dilution.
2Of 12 TAstV-2 positive samples tested, 8.3% positive to 1:1000, 75% positive to 1:10000, and 16.7% positive to 1:100000.
doi:10.1371/journal.pone.0096934.t001
Figure 1. Development of a competitive astrovirus ELISA. A)
Rabbit anti-HAstV-1 or TAstV-2 polyclonal antibodies were pre-
incubated with PBS (no treatment) or purified recombinant HAstV-1
or TAstV-2 capsid proteins then tested for binding to bound HAstV-1 or
TAstV-2 capsid protein by ELISA. *p,0.05. B) Specificity of the rabbit
polyclonal antibodies. Samples were run in at least duplicate and data
are shown as mean values. Error bars indicate SD.
doi:10.1371/journal.pone.0096934.g001
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groups. In contrast, we detected significant differences between the
study groups testing TAstV-2 positive. Antibodies were detected in
21.1% of the non-occupationally exposed subjects, 21.6% of the
turkey growers, and 45.5% of the processing plant workers
(p = 0.019) (Table 2). The odds of testing positive for TAstV-2
antibodies among processing plant workers was about 3 times
more than that among turkey growers or non-occupationally
exposed participants (OR=3.1, 95% CI: 1.3–7.5). Turkey growers
did not statistically differ from non-occupationally exposed
participants (OR=1.0, 95% CI: 0.4–2.5).
We then focused on determining the risk factors that may be
associated with having TAstV-2 antibodies among the processing
plant workers. Several potential risk factors were examined
including age, sex, race and ethnicity, smoking, and chronic
diseases. A set of occupational risk factors such as the use of gloves,
masks, aprons, boots, and eye protection along with the specific
tasks the individual performed in the plant were also studied. None
of these variables were significantly associated with having TAstV-
2 antibodies.
Figure 2. Specificity of the human sera to HAstV-1 and TAstV-2 capsid proteins. A) HAstV-1 positive sera were pre-incubated with PBS (no
treatment) or HAstV-1 or TAstV-2 capsid proteins and binding to HAstV-1 capsid protein assessed by ELISA. B) TAstV-2 positive sera were pre-
incubated with PBS (no treatment) or HAstV-1 or TAstV-2 capsid proteins and binding to TAstV-2 capsid protein assessed by ELISA. C) TAstV-2 positive
and negative sera were pre-incubated with PBS (no treatment) or chicken astrovirus and binding to TAstV-2 capsid protein assessed by ELISA. A plus
sign denotes serum sample was positive for indicated virus, and a minus sign denotes serum sample was negative for the indicated virus. Samples
were tested in duplicate and data shown are mean values; error bars indicate SD. *p,0.05.
doi:10.1371/journal.pone.0096934.g002
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Discussion
Nothing is known about the seroprevalence of non-human
mammalian and avian astroviruses in humans. Our results suggest
that a minority of people have antibodies to TAstV-2; however,
occupational exposure to turkeys can result in seroconversion.
This risk increases by working in a meat processing plant, but not
by raising turkeys. Processing plant workers spend more time in
contact with turkeys than do turkey growers, which may explain
the decreased evidence of seroconversion among turkey growers.
Processing plant workers have a wide spectrum of activities within
the meat processing plant, with exposure to live birds occurring
when unloading turkeys from transport vehicles, handling birds
within the plant, and cleaning and decontaminating trucks and
cages where live birds have been contained. These workers are
also routinely exposed to bird carcasses and body fluids. In our
study, workers involved in slaughtering the birds did not have a
significantly higher risk of seroconversion than other workers did.
In fact, none of the measured risk factors was associated with an
elevated antibody titer against TAstV-2. This outcome could be
due to the small sample size of processing plant workers.
Why did the ‘‘occupationally unexposed’’ group in Cohort C
have TAstV-2 antibodies? One possibility is cross-reactivity of the
HAstV-1 and TAstV-2 antibodies. The HAstV-1 and TAstV-2 are
genetically and structurally distinct [8,23] and antibodies pro-
duced to the specific capsids do not cross-react. Competitive
ELISAs demonstrated TAstV-2 positive sera were inhibited by
pre-incubation with TAstV-2 capsid, although inhibition may not
have been complete. This was not unexpected given that we were
unable to completely inhibit rabbit anti-TAstV-2 antibody binding
by pre-incubation with recombinant capsid protein. An alternative
possibility is exposure to a different avian astrovirus that cross-
reacts with the TAstV-2 antibody. Several strains of TAstV as well
as chicken astroviruses (CAstV) are known to circulate in
commercial poultry in the United States [25]. Although we
cannot definitively rule out this possibility, we found that CAstV
failed to inhibit TAstV-2 responses when pre-incubated with
TAstV-2 positive human sera. However, one caveat to this might
be that CAstV viral stocks were used for this assay, and the
concentration of CAstV capsid was probably far lower than a
purified recombinant capsid stock. Based on these findings, and
given that our two additional cohorts had no-to-minimal TAstV-2
positivity, we would hypothesize that although not occupationally
exposed to turkeys, this population, which is based in rural Iowa
and Illinois, was unknowingly exposed to TAstV-2. One possibility
is environmental exposure. Astroviruses are extremely stable and
can persist in the environment for long periods on surfaces [26].
Thus, employees in a turkey processing plant may be exposed to
TAstV-2 virus without direct contact with turkeys. Environmental
testing of abattoirs for TAstV-2 could prove interesting.
In conclusion, our results suggest that occupational exposure to
turkeys in processing plants is a risk factor for exposure to TAstV-
2. Is this finding unique to TAstV-2? We won’t be able to answer
this question until reagents to additional avian and non-human
mammalian astroviruses become available. Future studies are also
needed to determine whether such seroconversion events are
actually associated with clinical disease.
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